Literature DB >> 1117991

Prevention of the effects of fentanyl by immunological means.

M Torten, C H Miller, J H Eisele, G L Henderson, E Benjamini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1117991     DOI： 10.1038/253565a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.

Authors:  Michael D Raleigh; Federico Baruffaldi; Samantha J Peterson; Morgan Le Naour; Theresa M Harmon; Jennifer R Vigliaturo; Paul R Pentel; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2018-11-08       Impact factor: 4.030

2.  Vaccine blunts fentanyl potency in male rhesus monkeys.

Authors:  Rebekah D Tenney; Steven Blake; Paul T Bremer; Bin Zhou; Candy S Hwang; Justin L Poklis; Kim D Janda; Matthew L Banks
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

Review 3.  Development of vaccines to treat opioid use disorders and reduce incidence of overdose.

Authors:  Marco Pravetoni; Sandra D Comer
Journal:  Neuropharmacology       Date:  2019-06-04       Impact factor: 5.250

4.  Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.

Authors:  Lauren C Smith; Paul T Bremer; Candy S Hwang; Bin Zhou; Beverly Ellis; Mark S Hixon; Kim D Janda
Journal:  J Am Chem Soc       Date:  2019-06-25       Impact factor: 15.419

5.  A fentanyl vaccine constructed upon opsonizing antibodies specific for the Galα1-3Gal epitope.

Authors:  Jiaxing Wang; Beverly Ellis; Bin Zhou; Lisa M Eubanks; Steven Blake; Kim D Janda
Journal:  Chem Commun (Camb)       Date:  2020-05-12       Impact factor: 6.222

6.  Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.

Authors:  M D Raleigh; S J King; F Baruffaldi; A Saykao; F A Hamid; S Winston; M G LeSage; P R Pentel; M Pravetoni
Journal:  Neuropharmacology       Date:  2021-06-11       Impact factor: 5.273

Review 7.  Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?

Authors:  E Andrew Townsend; Matthew L Banks
Journal:  CNS Drugs       Date:  2020-05       Impact factor: 5.749
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.